Skip to content
healthcare.dev

SUBVENITE

NDC 69102-301, LAMOTRIGINE, tablet, from OWP Pharmaceuticals, Inc..

Product NDC
69102-301
Status
Listed
Labeler
OWP Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078947
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69102-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE25 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
69102-301-0169102030101100 TABLET in 1 BOTTLE (69102-301-01)
69102-301-02691020301026600 TABLET in 1 BOTTLE (69102-301-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7ad18b68-ba16-4810-9c3e-27fa970454e8
  • NADAC price for package 69102030101

    GET /v1/drugs/nadac/69102030101

Use it

Look up 69102-301 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69102-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69102-301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.